Response to "Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing".
| Image |  |
|---|---|
| Description | scientific article published in October 2017 |
| Author/s |
author: Joep Killestein |
| Publication date | October 9, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |